IMR Press / EJGO / Volume 29 / Issue 4 / pii/1630995690200-1689577370

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
Association study of vascular endothelial growth factor gene polymorphisms in endometrial carcinomas in a Japanese population
Show Less
1 Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe (Japan)
2 Nuffield Department of Obstetrics and Gynaecology, University of Oxford (UK)
Eur. J. Gynaecol. Oncol. 2008, 29(4), 333–337;
Published: 10 August 2008

Objective: Vascular endothelial growth factor (VEGF) is one of the most potent endothelial cell mitogens and plays a critical role in angiogenesis of endometrial carcinomas. Several studies have demonstrated positive associations between VEGF gene polymorphisms and several carcinomas. In this study we investigated whether VEGF gene polymorphisms are associated with endometrial carcinomas in a Japanese population. Methods: The allele frequencies and genotype distributions of VEGF -460 C/T, +405 G/C, and +936 C/T polymorphisms were examined in 105 endometrial carcinomas and 179 controls using PCR-RFLP analysis. An association of these polymorphisms with three-year disease-free survival was evaluated using the Kaplan-Meier method. Results: No significant differences in the allele frequencies and genotype distributions of VEGF -460 C/T (p = 0.54, 0.90), +405 G/C (p = 0.31, 0.17), and +936 C/T polymorphisms (p = 0.46, 0.24) were observed between endometrial carcinoma patients and controls. There were no significant differences in the frequencies of haplotype -460 T/+405 C between patients and controls. Futhermore, VEGF - 460 C/T, +405 G/C, and +936 C/T polymorphisms were not associated with three-year disease-free survival of endometrial carcinoma patients. Conclusions: Although limited by sample size, our study did not demonstrated any evidence that VEGF -460 C/T, +405 G/C, and +936 C/T polymorphisms are associated with an increased risk of endometrial carcinomas in Japanese women.
Endometrial carcinoma
Gene polymorphism
Polymerase chain reaction
Restriction fragment length polymorphism
Vascular endothselial growth factor
Back to top